Stockscreener 앱 받기
73.34
1.52%
-1.13
시간 외 거래:
73.34
전일 마감가:
$74.47
열려 있는:
$74.68
하루 거래량:
1.54M
Relative Volume:
0.98
시가총액:
$35.75B
수익:
$10.40B
순이익/손실:
$980.00M
주가수익비율:
37.14
EPS:
1.9749
순현금흐름:
$1.61B
1주 성능:
-0.42%
1개월 성능:
-15.88%
6개월 성능:
-0.78%
1년 성능:
-24.24%
1일 변동 폭
$73.21
$74.80
1주일 범위
$73.12
$76.35
52주 변동 폭
$71.55
$99.20
Alcon Inc Stock (ALC) Company Profile
Compare ALC vs ISRG, BDX, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
73.34 | 35.75B | 10.40B | 980.00M | 1.61B | 1.9749 |
ISRG
Intuitive Surgical Inc
|
452.66 | 160.77B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
154.51 | 43.95B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
41.36 | 33.57B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
220.47 | 32.12B | 5.40B | 1.49B | 1.78B | 10.12 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-26 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2026-01-30 | 개시 | William Blair | Mkt Perform |
| 2026-01-20 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2026-01-09 | 다운그레이드 | Stifel | Buy → Hold |
| 2025-12-11 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2025-08-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-05-20 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2025-05-14 | 재확인 | BTIG Research | Buy |
| 2025-03-28 | 재확인 | Needham | Buy |
| 2025-03-25 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-01-24 | 재확인 | Needham | Buy |
| 2025-01-10 | 업그레이드 | Redburn Atlantic | Neutral → Buy |
| 2024-12-17 | 재확인 | Needham | Buy |
| 2024-11-12 | 재확인 | Needham | Buy |
| 2024-10-10 | 업그레이드 | Redburn Atlantic | Sell → Neutral |
| 2024-09-10 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-07-15 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2024-05-15 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2024-04-10 | 개시 | Goldman | Buy |
| 2024-03-14 | 개시 | RBC Capital Mkts | Sector Perform |
| 2024-02-06 | 재개 | KeyBanc Capital Markets | Overweight |
| 2024-01-23 | 개시 | Bernstein | Outperform |
| 2023-12-18 | 다운그레이드 | Redburn Atlantic | Neutral → Sell |
| 2023-12-12 | 개시 | Stifel | Buy |
| 2023-12-04 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2023-08-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-05-10 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2023-03-01 | 업그레이드 | Societe Generale | Sell → Hold |
| 2022-12-22 | 개시 | Mizuho | Buy |
| 2022-11-17 | 다운그레이드 | Societe Generale | Hold → Sell |
| 2022-08-11 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2022-05-13 | 재개 | Credit Suisse | Outperform |
| 2022-05-12 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2022-04-08 | 개시 | Needham | Buy |
| 2022-03-11 | 개시 | BofA Securities | Buy |
| 2022-01-18 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2022-01-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | 개시 | Oppenheimer | Perform |
| 2021-07-14 | 개시 | Deutsche Bank | Buy |
| 2021-05-06 | 업그레이드 | Citigroup | Sell → Neutral |
| 2021-03-22 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-11-12 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-07-06 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2020-07-06 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-06-16 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-04-08 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | 업그레이드 | Argus | Hold → Buy |
| 2020-03-24 | 업그레이드 | Societe Generale | Sell → Hold |
| 2020-03-13 | 업그레이드 | UBS | Neutral → Buy |
| 2020-03-05 | 개시 | Citigroup | Neutral |
| 2020-02-26 | 업그레이드 | Berenberg | Hold → Buy |
| 2020-01-08 | 개시 | Argus | Hold |
| 2019-10-29 | 개시 | Stephens | Equal-Weight |
| 2019-08-21 | 재확인 | BofA/Merrill | Neutral |
| 2019-06-24 | 개시 | SVB Leerink | Mkt Perform |
| 2019-06-14 | 개시 | BTIG Research | Neutral |
| 2019-05-10 | 개시 | Robert W. Baird | Outperform |
| 2019-05-02 | 개시 | Credit Suisse | Outperform |
모두보기
Alcon Inc 주식(ALC)의 최신 뉴스
Alcon Inc Stock: Global Leader in Eye Care with Strong Growth Potential for North American Investors - AD HOC NEWS
Alcon announces $81 million expansion in Cabell County, 75 new jobs expected - wowktv.com
Alcon Inc Stock: Global Leader in Eye Care Innovation and Steady Growth Potential for Investors - AD HOC NEWS
Alcon Inc. Stock: A Leader in Eye Care Innovation Driving Steady Growth for North American Investors - AD HOC NEWS
Alcon expansion to create more West Virginia jobs - wowktv.com
Systane Eye Drops: Alcon's Leading Solution for Dry Eye Relief in North America - AD HOC NEWS
Analyst Upgrade: Is Alcon Inc benefiting from innovation trendsPortfolio Update Report & Expert Verified Movement Alerts - baoquankhu1.vn
Lensar stock slumps after hours on ending merger deal with Alcon over FTC pushback - MSN
Alcon Inc stock faces uncertainty as Lensar merger collapses, pivots to organic growth strategy - AD HOC NEWS
LENSAR Inc stock plunges as Alcon terminates merger over FTC antitrust block - AD HOC NEWS
LENSAR Inc stock faces prolonged uncertainty as Alcon merger awaits FTC approval amid regulatory del - AD HOC NEWS
LENSAR Inc stock faces uncertainty as Alcon merger awaits final regulatory approval amid pending FTC - AD HOC NEWS
World Council of Optometry and Alcon Introduce Dry Eye Management Map - VisionMonday.com
Alcon Inc stock faces uncertainty as Lensar merger collapses, prompting strategic pivot to core eye - AD HOC NEWS
ALC Stock Price, Quote & Chart | ALCON INC (NYSE:ALC) - ChartMill
BTIG Reiterates 'Buy' Rating for Alcon (ALC) with $92 Price Targ - GuruFocus
Eaton Vance Worldwide Health Sciences Fund's Alcon Inc(XSWX:ALC) Holding History - GuruFocus
US LASIK Treatment Market Set to Witness Rapid Growth Through - openPR.com
Alcon Inc. stock faces steady demand amid eye care sector shifts and portfolio updates - AD HOC NEWS
Is It Time To Reassess Alcon (SWX:ALC) After A 26.9% Share Price Slide? - Yahoo Finance
STAAR Surgical Co stock faces acquisition scrutiny as Alcon deal advances amid analyst caution - AD HOC NEWS
Guidance Update: Should I invest in Alcon Inc before earnings2026 Top Decliners & Comprehensive Market Scan Insights - baoquankhu1.vn
Alcon Inc stock faces pressure amid terminated LENSAR merger and market downturn - AD HOC NEWS
Alcon Inc. stock faces headwinds amid surgical slowdown and tariff risks in eye care sector - AD HOC NEWS
Alcon, LENSAR abandon proposed merger amidst FTC pushback - Ophthalmology Times
Alcon Inc. stock gains momentum as AlphaValue upgrades rating to Buy amid eye care sector resilience - AD HOC NEWS
Lensar agrees to terminate sale to Alcon - MSN
Systane Eye Drops Lead Alcon's Shift to Organic Growth After Lensar Deal Collapse - AD HOC NEWS
Alcon and Lensar terminate proposed merger after FTC pressure - Eyes On Eyecare
EV Market: Can Alcon Inc outperform in the next rally2026 Price Targets & Long-Term Growth Stock Strategies - baoquankhu1.vn
Alcon And LENSAR: Why The Broken Merger Creates Two Different Buy Cases (NYSE:ALC) - Seeking Alpha
Alcon and Lensar Agree to Terminate Merger Agreement - VisionMonday.com
BTIG upgrades Lensar stock rating to buy after Alcon deal ends - Investing.com Canada
ACQUISITIONS & MERGERS NEWS: FTC successfully blocks Alcon-LENSAR merger in cataract surgery laser market - VitalLaw.com
BTIG upgrades Lensar stock rating to buy after Alcon deal ends By Investing.com - Investing.com South Africa
Alcon Drops $430M Lensar Deal Under Pressure From FTC - Law360
Alcon abandons effort to purchase LENSAR after FTC scrutiny - MedTech Dive
LENSAR Terminates Merger Agreement with Alcon Following FTC Challenge, Retains $10M Deposit and Announces Strategic Update - Minichart
Lensar Share Slide on Terminated Merger Deal With Alcon - marketscreener.com
Alcon, LENSAR terminate merger agreement after US FTC opposition - MLex
Alcon, LENSAR Halt Merger Deal Amid FTC Scrutiny - Medical Product Outsourcing
US FTC stops proposed merger of Alcon, LENSAR - MLex
US FTC Says It Stops Proposed Merger Of Cataract-Surgery Device Makers Lensar And Alcon - TradingView
LENSAR Stock Plunges—Alcon Scraps Merger After Prolonged Regulatory Review - Benzinga
LENSAR Stock Plunges—Alcon Scraps Merger After Prolonged Regulatory Review - Benzinga
LENSAR Ends Alcon Merger, Plans Strategic Update - TipRanks
Lensar and Alcon Sign Termination Agreement; Lensar Retains $10 Million Deposit - TradingView
LENSAR (NASDAQ: LNSR) terminates Alcon merger, retains $10M and plans strategy update - Stock Titan
Alcon Inc stock terminates Lensar merger amid US regulatory hurdles, shifts focus to core growth - AD HOC NEWS
Lensar to terminate Alcon merger agreement - Yahoo Finance
Switzerland: Alcon and Lensar agree to terminate merger agreement - Investors in Healthcare
Alcon Inc (ALC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.01%
자본화:
|
볼륨(24시간):